All In Biotech

Drug Trial Radar · NCT06157918

Relative Bioavailability and Food Effect of SYHA1813 Oral Solution in Healthy Participants

A Single-Center, Randomized, Open-label, Single-dose, 3-Sequence, 3-Period Rossover Design to Evaluate the Relative Bioavailability and Food Effect of SYHA1813 Oral Solution in Healthy Participants

Last checked: Nov 20, 2026Latest source record: Nov 8, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

19

Actual

Start

Dec 20, 2023

Primary completion

Jan 26, 2024

Study completion Jan 26, 2024

Sponsor

Sponsor type
Industry
First posted
Dec 6, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Male only, from 18 years, up to 60 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a three-period crossover phase I study designed to evaluate the relative bioavailability, food effect, safety and tolerability of SYHA1813 oral solution in healthy participants.

Conditions

  • Healthy Participants

Interventions

  • SYHA1813 oral solution (2.0g:25mg)Drug

    SYHA1813 oral solution, 25mg, oral

  • SYHA1813 oral solution (20ml:200mg)Drug

    SYHA1813 oral solution, 25mg, oral

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. CmaxTime frame: Up to 120 hours post-dose for eachperiod
  2. AUC0-∞Time frame: Up to 120 hours post-dose for eachperiod
  3. AUC0-tTime frame: Up to 120 hours post-dose for eachperiod

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology

    Shanghai, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.